September 28, 2026: FDA warns compounding pharmacy for producing “inordinate amounts” of weight loss drugs for identical prescriptions
The FDA issued a warning letter to Empower Pharmacy , a Texas-based 503A compounding facility, for continuing to manufacture “inordinate amounts” of weight loss drugs that are…
DO
By Daniel Okafor · Regulatory Correspondent
Sep 28 03:00 ETSource: Partnership for Safe Medicines
From the source
Read at safemedicines.orgSeptember 28, 2026: FDA warns compounding pharmacy for producing “inordinate amounts” of weight loss drugs for identical prescriptions
The FDA issued a warning letter to Empower Pharmacy , a Texas-based 503A compounding facility, for continuing to manufacture “inordinate amounts” of weight loss drugs that are essentially copies of brand-name products, which is no longer permitted now that shortages have resolved. The agency also said the inspection found that prescriber determinations of “significant difference” for the medicatio
